C-펩타이드 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "C-펩타이드" in Korean language version.

refsWebsite

Global rank Korean rank

15doi.org

2^nd place

3^rd place

15nih.gov

4^th place

2semanticscholar.org

11^th place

310^th place

2archive.org

6^th place

18^th place

1worldcat.org

5^th place

11^th place

archive.org

Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G (July 2001). “C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat”. 《Diabetologia》 44 (7): 889–97. doi:10.1007/s001250100570. PMID 11508275.
Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Sjöquist M (October 2001). “Effects of C-peptide on glomerular and renal size and renal function in diabetic rats”. 《Kidney International》 60 (4): 1258–65. doi:10.1046/j.1523-1755.2001.00964.x. PMID 11576340.

doi.org

dx.doi.org

Steiner DF, Cunningham D, Spigelman L, Aten B (August 1967). “Insulin biosynthesis: evidence for a precursor”. 《Science》 157 (3789): 697–700. doi:10.1126/science.157.3789.697. PMID 4291105. S2CID 29382220.
Brandenburg, Dietrich (2008). “History and Diagnostic Significance of C-Peptide”. 《Experimental Diabetes Research》 2008: 576862. doi:10.1155/2008/576862. ISSN 1687-5214. PMC 2396242. PMID 18509495.
Hills CE, Brunskill NJ (2008). “Intracellular signalling by C-peptide”. 《Experimental Diabetes Research》 2008: 635158. doi:10.1155/2008/635158. PMC 2276616. PMID 18382618.
Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G (July 2001). “C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat”. 《Diabetologia》 44 (7): 889–97. doi:10.1007/s001250100570. PMID 11508275.
Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Sjöquist M (October 2001). “Effects of C-peptide on glomerular and renal size and renal function in diabetic rats”. 《Kidney International》 60 (4): 1258–65. doi:10.1046/j.1523-1755.2001.00964.x. PMID 11576340.
Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, 외. (March 2005). “C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats”. 《Nephrology, Dialysis, Transplantation》 20 (3): 532–8. doi:10.1093/ndt/gfh683. PMID 15665028.
Nordquist L, Brown R, Fasching A, Persson P, Palm F (November 2009). “Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption”. 《American Journal of Physiology. Renal Physiology》 297 (5): F1265–72. doi:10.1152/ajprenal.00228.2009. PMC 2781335. PMID 19741019.
Nordquist L, Wahren J (2009). “C-Peptide: the missing link in diabetic nephropathy?”. 《The Review of Diabetic Studies》 6 (3): 203–10. doi:10.1900/RDS.2009.6.203. PMC 2827272. PMID 20039009.
Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M (August 2008). “Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway”. 《Diabetologia》 51 (8): 1534–43. doi:10.1007/s00125-008-1032-x. PMID 18493738.
Mughal RS, Scragg JL, Lister P, Warburton P, Riches K, O'Regan DJ, 외. (August 2010). “Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein”. 《Diabetologia》 53 (8): 1761–71. doi:10.1007/s00125-010-1736-6. PMC 2892072. PMID 20461358.
Koska J, Nuyujukian DS, Bahn G, Zhou JJ, Reaven PD (2021). “Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)”. 《Cardiovascular Diabetology》 20. doi:10.1186/s12933-021-01418-z. PMID 34879878.
Jones AG, Hattersley AT (July 2013). “The clinical utility of C-peptide measurement in the care of patients with diabetes”. 《Diabetic Medicine》 30 (7): 803–17. doi:10.1111/dme.12159. PMC 3748788. PMID 23413806.
Clark PM (September 1999). “Assays for insulin, proinsulin(s) and C-peptide”. 《Annals of Clinical Biochemistry》. 36 ( Pt 5) (5): 541–64. doi:10.1177/000456329903600501. PMID 10505204.
Shapiro ET, Tillil H, Rubenstein AH, Polonsky KS (November 1988). “Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration”. 《The Journal of Clinical Endocrinology and Metabolism》 67 (5): 1094–9. doi:10.1210/jcem-67-5-1094. PMID 3053748.
R, Chandini; Udayabhaskaran V; Binoy J Paul; K.P Ramamoorthy (July 2013). “A study of non-obese diabetes mellitus in adults in a tertiary care hospital in Kerala, India”. 《International Journal of Diabetes in Developing Countries》 33 (2): 83–85. doi:10.1007/s13410-013-0113-7. S2CID 71767996.

nih.gov

ncbi.nlm.nih.gov

Steiner DF, Cunningham D, Spigelman L, Aten B (August 1967). “Insulin biosynthesis: evidence for a precursor”. 《Science》 157 (3789): 697–700. doi:10.1126/science.157.3789.697. PMID 4291105. S2CID 29382220.
Brandenburg, Dietrich (2008). “History and Diagnostic Significance of C-Peptide”. 《Experimental Diabetes Research》 2008: 576862. doi:10.1155/2008/576862. ISSN 1687-5214. PMC 2396242. PMID 18509495.
Hills CE, Brunskill NJ (2008). “Intracellular signalling by C-peptide”. 《Experimental Diabetes Research》 2008: 635158. doi:10.1155/2008/635158. PMC 2276616. PMID 18382618.
Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G (July 2001). “C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat”. 《Diabetologia》 44 (7): 889–97. doi:10.1007/s001250100570. PMID 11508275.
Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Sjöquist M (October 2001). “Effects of C-peptide on glomerular and renal size and renal function in diabetic rats”. 《Kidney International》 60 (4): 1258–65. doi:10.1046/j.1523-1755.2001.00964.x. PMID 11576340.
Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, 외. (March 2005). “C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats”. 《Nephrology, Dialysis, Transplantation》 20 (3): 532–8. doi:10.1093/ndt/gfh683. PMID 15665028.
Nordquist L, Brown R, Fasching A, Persson P, Palm F (November 2009). “Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption”. 《American Journal of Physiology. Renal Physiology》 297 (5): F1265–72. doi:10.1152/ajprenal.00228.2009. PMC 2781335. PMID 19741019.
Nordquist L, Wahren J (2009). “C-Peptide: the missing link in diabetic nephropathy?”. 《The Review of Diabetic Studies》 6 (3): 203–10. doi:10.1900/RDS.2009.6.203. PMC 2827272. PMID 20039009.
Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M (August 2008). “Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-kappaB pathway”. 《Diabetologia》 51 (8): 1534–43. doi:10.1007/s00125-008-1032-x. PMID 18493738.
Mughal RS, Scragg JL, Lister P, Warburton P, Riches K, O'Regan DJ, 외. (August 2010). “Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human saphenous vein”. 《Diabetologia》 53 (8): 1761–71. doi:10.1007/s00125-010-1736-6. PMC 2892072. PMID 20461358.
Koska J, Nuyujukian DS, Bahn G, Zhou JJ, Reaven PD (2021). “Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)”. 《Cardiovascular Diabetology》 20. doi:10.1186/s12933-021-01418-z. PMID 34879878.
Jones AG, Hattersley AT (July 2013). “The clinical utility of C-peptide measurement in the care of patients with diabetes”. 《Diabetic Medicine》 30 (7): 803–17. doi:10.1111/dme.12159. PMC 3748788. PMID 23413806.
Clark PM (September 1999). “Assays for insulin, proinsulin(s) and C-peptide”. 《Annals of Clinical Biochemistry》. 36 ( Pt 5) (5): 541–64. doi:10.1177/000456329903600501. PMID 10505204.
Shapiro ET, Tillil H, Rubenstein AH, Polonsky KS (November 1988). “Peripheral insulin parallels changes in insulin secretion more closely than C-peptide after bolus intravenous glucose administration”. 《The Journal of Clinical Endocrinology and Metabolism》 67 (5): 1094–9. doi:10.1210/jcem-67-5-1094. PMID 3053748.

pubchem.ncbi.nlm.nih.gov

C-Peptide - Compound Summary, PubChem.

semanticscholar.org

api.semanticscholar.org

Steiner DF, Cunningham D, Spigelman L, Aten B (August 1967). “Insulin biosynthesis: evidence for a precursor”. 《Science》 157 (3789): 697–700. doi:10.1126/science.157.3789.697. PMID 4291105. S2CID 29382220.
R, Chandini; Udayabhaskaran V; Binoy J Paul; K.P Ramamoorthy (July 2013). “A study of non-obese diabetes mellitus in adults in a tertiary care hospital in Kerala, India”. 《International Journal of Diabetes in Developing Countries》 33 (2): 83–85. doi:10.1007/s13410-013-0113-7. S2CID 71767996.

worldcat.org

Brandenburg, Dietrich (2008). “History and Diagnostic Significance of C-Peptide”. 《Experimental Diabetes Research》 2008: 576862. doi:10.1155/2008/576862. ISSN 1687-5214. PMC 2396242. PMID 18509495.